Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Macular degeneration Stories

2014-01-22 16:26:02

Prescription or Non-prescription, BluTech Lenses Provide Protection from Harmful Blue Light PHOENIX, Jan. 22, 2014 /PRNewswire/ -- Eye Solutions Technologies, LLC, a Phoenix-based company dedicated to providing smart eye protection for everyone, introduces the most technologically advanced prescription and non-prescription lenses available. Based on science and derived from nature, BluTech® Lenses filter harmful, high-energy blue light which impairs daily visual performance,...

2014-01-22 12:26:53

LONDON, Jan. 22, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Macular Degeneration Therapeutics Market in Asia-Pacific to 2019 - Existing Angiogenics Retain Dominance Though High Unmet Need RemainsMacular Degeneration Therapeutics Market in Asia-Pacific to 2019 - Existing Angiogenics Retain Dominance Though High Unmet Need Remains SummaryGBI Research has released its research, "Macular Degeneration Therapeutics Market in Asia-Pacific to 2019 -...

2014-01-20 10:24:51

Findings are published in special issue of IOVS Aging gracefully may not be an option for the 40 million people worldwide who are blind or have significant visual impairment. It's reported that 65% of those with visual impairment and 82% of those who are blind are over 50 years of age. In a special issue of Investigative Ophthalmology & Visual Science (IOVS), ophthalmic leaders from around the world address "the aging eye" to focus attention on unmet needs and accelerate the...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

Eye Gene Therapy
2014-01-16 09:44:41

Brett Smith for redOrbit.com - Your Universe Online A newly developed genetic therapy for treating a type of inherited blindness called choroideremia is showing some promise and allowing patients to see incrementally more than they had before the treatment, according to a new report in The Lancet. Six patients in the study had one eye treated with the gene therapy in operations at the Oxford Eye Hospital in the United Kingdom. After six months, the treated eye showed improved vision in...

2014-01-13 16:26:26

GENEVA, Jan. 13, 2014 /PRNewswire/ -- Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs announced today that Opthea Pty Ltd has entered into a commercial license agreement with Selexis covering the use of the CHO-M Cell Line and related technologies for the production of OPT-302 (formerly VGX-300), an Fc fusion protein for the treatment of wet Age-Related...

2014-01-09 00:21:38

Report Examines the Impact of Digital Media on Vision Health ALEXANDRIA, Va., Jan. 9, 2014 /PRNewswire/ -- A report released today at the 2014 Consumer Electronics Show by The Vision Council finds that nearly 70 percent of U.S. adults experience digital eye strain while on digital devices - including computers, tablets and smartphones. Yet, about half of adults don't know how to or have never tried to reduce their visual discomfort. As the market experiences a surge in high technology-related...

Scientists Use Drug To Repair Rare Birth Defect
2013-12-22 17:37:52

University of British Columbia Success in mouse model is first instance of drug reversing a congenital deformity University of British Columbia and Vancouver Coastal Health scientists have developed a potential cure for a rare eye disease, showing for the first time that a drug can repair a birth defect. They formulated the drug Ataluren into eye drops, and found that it consistently restored normal vision in mice who had aniridia (ANN-uh-ridee- uh), a condition that severely limits...

2013-12-18 23:01:23

Low Vision optometrist and nutritionist John M. Pino O.D., Ph.D., the only International Academy of Low Vision Specialists (IALVS) doctor in Tennessee, holds a doctorate in nutrition. Dr. Pino concurs with a study in the American Journal of Clinical Nutrition suggesting that taking certain B vitamins may prevent Age Related Macular Degeneration (AMD). Lebanon, Tennessee (PRWEB) December 18, 2013 While it’s normal for eyesight to decline over the years, some of the leading causes of...

2013-12-18 08:28:42

TARRYTOWN, N.Y., Dec. 18, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from submission, for a target action...